Correction to Lancet Oncol 2024; 25: 1625–34

Abstract

Vora S, Pafundi D, Voss M, et al. Short-course hypofractionated proton beam therapy, incorporating ¹⁸F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial. Lancet Oncol 2024; 25: 1625–34—In this Article, the spelling of author Bernard R Bendok's name was incorrect. This correction has been made to the online version as of Jan 2, 2025.